The Boston Globe featured OpenBiome in a discussion about how to advance safety and research on fecal transplants. A timely topic, the piece reflects on recent enthusiasm for FMT and the opportunities that exist for advancing our understanding of the treatment. Here is an excerpt:
"The excitement about the successful use of fecal transplants to treat the gastrointestinal infection C. difficile has also led to a premature interest among the general public suffering from ailments for which it is completely unproven and untested. “I have pretty serious concerns about this,” said Mark Smith, a graduate student in microbiology at MIT who co-wrote the paper published in Nature. “It’s an exciting area of research, but it’s not ready for every patient to get their hands on.”
Here's the full piece.